Chara Stavraka
- Oncology top 10%
- Cancer Treatment and Pharmacology 5
- Colorectal Cancer Treatments and Studies 4
- Pancreatic and Hepatic Oncology Research 3
- Cancer-related Molecular Pathways 3
- PARP inhibition in cancer therapy 3
- Reproductive Medicine top 10%
-
- Cancer Genomics and Diagnostics 5
-
- Mast cells and histamine 5
-
- Chronic Lymphocytic Leukemia Research 3
- Co-authors
- Sarah P. BlagdenHannah RushPaul J. RossHani GabraDavid J. PinatoSadaf Ghaem‐MaghamiJames SpicerDebra H. Josephs
- Journals
- Journal of Clinical Oncology (5 papers)SHILAP Revista de lepidopterología (3 papers)PLoS ONE (2 papers)
- Partner nations
- United KingdomGreeceUnited States
In The Last Decade
Chara Stavraka
44 papers receiving 749 citations
Peers
Comparison fields: 5 of 84
- Oncology 322
- Reproductive Medicine 64
- Cancer Research 106
- Immunology 128
- Hepatology 33
Countries citing papers authored by Chara Stavraka
This map shows the geographic impact of Chara Stavraka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chara Stavraka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chara Stavraka more than expected).
Fields of papers citing papers by Chara Stavraka
This network shows the impact of papers produced by Chara Stavraka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chara Stavraka. The network helps show where Chara Stavraka may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chara Stavraka, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2021 | 15 | |
| 3 | 2021 | 24 | |
| 4 | 2021 | 31 | |
| 5 | 2020 | 2 | |
| 6 | 2020 | 32 | |
| 7 | 2020 | 27 | |
| 8 | 2020 | 16 | |
| 9 | 2020 | 31 | |
| 10 | 2020 | 17 | |
| 11 | 2020 | 3 | |
| 12 | 2020 | 14 | |
| 13 | 2019 | 13 | |
| 14 | 2019 | 7 | |
| 15 | 2018 | 92 | |
| 16 | The RNA-binding protein LARP1 is a cancer therapeutic target | 2017 | 1 |
| 17 | 2017 | 1 | |
| 18 | 2015 | 39 | |
| 19 | 2014 | 36 | |
| 20 | 2011 | 69 |
About Chara Stavraka
Chara Stavraka is a scholar working on Oncology, Genetics and Immunology and Allergy, having authored 45 papers that have together received 755 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (5 papers), Cancer Treatment and Pharmacology (5 papers), Mast cells and histamine (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Chronic Lymphocytic Leukemia Research (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Cancer-related Molecular Pathways (3 papers) and PARP inhibition in cancer therapy (3 papers). The work is most often cited by research in Oncology (322 citations), Reproductive Medicine (64 citations) and Cancer Research (106 citations). Chara Stavraka has collaborated with scholars based in United Kingdom, Greece and United States. Frequent co-authors include Sarah P. Blagden, Hannah Rush, Paul J. Ross, Hani Gabra, David J. Pinato, Sadaf Ghaem‐Maghami, James Spicer, Debra H. Josephs, Roshan Agarwal and Sophia N. Karagiannis. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.